Nanomedicine News

RSS

Nano-Diagnostics Company Appoints Gannon to Scientific Advisory Board

AION Diagnostics Inc, a nano-diagnostics company commercializing medical imaging agents, announced today the appointment of William E. Gannon Jr., M.D., M.B.A., expert in clinical and regulatory affairs, to its Scientifi...

5 Jun 2007

Correcting Vision Using DNA Nanoparticles

Copernicus Therapeutics, Inc. announced today that a research team at University of Oklahoma Health Sciences Center, led by Dr. Muna Naash, Professor of Cell Biology, demonstrated that Copernicus’ DNA nanoparticles...

5 Jun 2007

Polymer-Free Nanoscale Microporous Hydroxyapatite Drug-Eluting Stents Being Evaluated

MIV Therapeutics, a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, today announced the first ever human imp...

1 Jun 2007

Bioconjugated Quantum Dots Effectively Identify Biomarkers in Cancerous Tissues

Bioconjugated quantum dots – luminescent nanoparticles linked to biological molecules – have shown great promise as tools for disease diagnosis and treatment, but their medical use has been limited by the lac...

30 May 2007

Physicists Aim to Improve Positron Emission Tomography Technology

Physicists are developing new electronics for identifying subatomic particles in high-energy accelerators that may also enable radiologists to detect cancer at an earlier, more curable stage. “The electronics ne...

23 May 2007

NanoMed Pharmaceuticals Elects Gabriel Leung to Board

NanoMed Pharmaceuticals has announced today that it has elected to its Board of Directors, Gabriel Leung, President, Oncology, at OSI Pharmaceuticals, a leading biotechnology company and maker of Tarceva. "We ar...

23 May 2007

Bioconjugated Quantum Dots for Multiplex and Quantitative Immunohistochemistry

Quantum dots linked to biological molecules, such as antibodies, have shown promise as a new tool for detecting and quantifying a wide variety of cancer-associated molecules. Now, thanks to detailed studies of how to mak...

23 May 2007

Nanoparticulate Delivery of Suicide DNA to Murine Prostate and Prostate Tumors

Using nanoparticles developed by members of the Alliance for Nanotechnology in Cancer, a team of investigators at the Lankenau Institute for Medical Research, in Philadelphia, has developed a DNA-based therapeutic agent ...

23 May 2007

Nanoparticle Self-Assembly Gated by Logical Proteolytic Triggers

There is a growing recognition among cancer researchers that the most accurate methods for detecting early-stage cancer will require the development of sensitive assays that can identify simultaneously multiple biomarker...

23 May 2007

Analyzing Nanoparticle Levels in Blood

With the race to develop nanoparticle-based therapeutics and imaging agents for cancer applications moving at full speed, a small but growing group of researchers is quietly developing the methods that are needed to full...

23 May 2007